These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 7068280)

  • 1. Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice.
    Parmiani G; Sensi ML; Carbone G; Colombo M; Pierotti M; Ballinari D; Hilgers J; Hilkens J
    Int J Cancer; 1982 Mar; 29(3):323-32. PubMed ID: 7068280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive adoptive immunotherapy of low-immunogenic BALB/c lymphoma by syngeneic alloimmune T lymphocytes.
    Colombo MP; Arioli I; Parmiani G
    Int J Cancer; 1984 Dec; 34(6):807-13. PubMed ID: 6334656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of alien minor histocompatibility antigens distinct from tumor-specific transplantation antigen on a murine fibrosarcoma.
    Parmiani G; Colombo M; Ballinari D
    Int J Cancer; 1980 Oct; 26(4):461-5. PubMed ID: 7251224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of non-H-2 genes in the control of the in vivo growth of the virus induced lymphoma YC8.
    Colombo MP; Parmiani G
    J Immunogenet; 1981 Oct; 8(5):405-13. PubMed ID: 6795282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the cellular immune response to and adoptive immunotherapy of a BALB/c lymphoma that cross-reacts with normal DBA/2 cells.
    Sensi M; Grazioli L; Parmiani G
    Cancer Immunol Immunother; 1986; 21(3):199-204. PubMed ID: 2938737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studies.
    Parmiani G; Invernizzi G
    Int J Cancer; 1975 Nov; 16(5):756-67. PubMed ID: 52628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
    Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
    Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive therapy of established syngeneic leukemia by cells primarily sensitized in vitro.
    Cheever MA; Greenberg PD; Fefer A
    Cancer Res; 1981 Jul; 41(7):2658-63. PubMed ID: 7018668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DBA/2-like minor histocompatibility antigens on a BALB/c lymphoma. A BALB/c anti-DBA/2 serum which lyses the tumor and blocks BALB/c anti-tumor and anti-DBA/2 effectors.
    Ballinari D; Grazioli L; Sensi ML; Borrello MG; Parmiani G
    Int J Cancer; 1985 Nov; 36(5):617-22. PubMed ID: 3877002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: characterization of the effector population and evidence for the role of the host's non-T cells.
    Colombo MP; Parenza M; Parmiani G
    Cancer Immunol Immunother; 1985; 20(3):198-204. PubMed ID: 3851699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological characteristics of leukemia and lymphoma in allogeneic cell immunity: growth of syngeneic tumors in rats immunized with allogeneic cells.
    Hosokawa M; Yamashita T; Gotohda E; Takeichi N; Kodama T; Kobayashi H
    Int J Cancer; 1978 Jul; 22(1):91-7. PubMed ID: 681026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice.
    Fioretti MC; Libarati M; Bonmassar E; Cudkowicz G
    Cancer Res; 1975 Jan; 35(1):30-6. PubMed ID: 1089042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against syngeneic tumor grafts induced by inoculation with normal allogeneic tissues.
    Bear RH; Roholt OA; Pressman D
    Immunol Commun; 1977; 6(6):547-58. PubMed ID: 342393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of the anti-tumour immune response by suppressor gene products of lymphoid cells.
    De Giorgi L; Matossian-Rogers A; Festenstein H
    Immunology; 1979 Apr; 36(4):711-8. PubMed ID: 108205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syngeneic and allogeneic mouse lymphoma antisera: specificity, reaction with fetal antigen and protective capacity.
    Prager MD; Granatek CH; Ludden CM
    Isr J Med Sci; 1976; 12(4-5):325-33. PubMed ID: 939692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple foreign non-H-2 determinants on the surface of a chemically-induced murine sarcoma.
    Invernizzi G; Carbone G; Meschini A; Parmiani G
    J Immunogenet; 1977 Apr; 4(2):97-106. PubMed ID: 874338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth of transplantable melanoma and leukaemia and prevention of virus-induced leukaemia in long lived radiation chimeras constructed with unmanipulated bone marrow.
    Pierpaoli W
    Clin Exp Immunol; 1985 Jan; 59(1):210-6. PubMed ID: 3882284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.